NUVB
NUVB
NYSE · Pharmaceuticals

Nuvation Bio Inc

$4.22
-0.04 (-0.94%)
As of Mar 22, 10:04 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +924.2% upside
Low Target $30.63
Average Target $43.22
High Target $69.64
Current Price $4.22
Current
$4.22
Target
$43.22
$30.63 $43.22 avg $69.64
Scenario Analysis
Bear Case
$30.63
625.8%
Low target
Base Case
$43.22
+924.2%
Avg target
Bull Case
$69.64
+1,550.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.75
-56.7% from high
52-Week Low
$1.54
+174.0% from low
Target vs 52W High
$43.22
+343.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%